For the Culture By The Culture. ISSN: 3064-9331.
Ohio voters approved adult use cannabis with 57 percent support in 2023. Two years later, lawmakers narrowed that framework through Senate Bill 56. A referendum campaign now seeks to overturn those revisions, requiring roughly 248,000 valid signatures statewide. This piece breaks down what changed, who changed it, and what voters are being asked to decide next.
THE CANNABIS LIE is a reporting series examining how cannabis policy turns shaky assumptions into hard penalties. In THE CANNABIS LIE: Vol. 2, The Fiction of Impairment, THC detection is often treated like proof of impairment, even though blood levels show a weak, inconsistent relationship to functional driving ability. This installment explains why per se THC limits and zero tolerance rules create false certainty, why urine metabolites only show prior exposure, and why real impairment should be demonstrated through behavior and context, not presumed from a lab result.
This new investigative series begins by confronting one of cannabis policy’s most durable myths. THC percentage became a convenient shortcut for harsher laws, even though higher potency has never equaled greater danger. Vol. 1 documents how numbers replaced evidence and how courts, media, and policy still punish people for a claim that cannot survive scrutiny.
A new study claims cannabis can be measured like alcohol using weekly limits and risk tiers. This feature dismantles that framework, exposing how alcohol math distorts cannabis science, ignores human biology, and fuels modern prohibition under the guise of public health. Numbers may comfort regulators, but they do not reflect reality.
Texas regulators are moving to eliminate smokable cannabis without passing a law. After lawmakers failed to ban THC products, state agencies rewrote testing standards and imposed crushing fees that push legal cannabis out of reach. The result is prohibition by process, driven by selective morality, political pressure, and regulatory maneuvering.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
